All In Biotech

Free tool

FAERS Monitor: Clobex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021644 or its brand name (Clobex, Clobetasol Propionate). Reports on generic versions are filed under their own applications.

Reports

10,595

Serious

4,972

47% of reports

Hospitalization

2,058

Death reported

439

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,087
  • pruritus983
  • off label use682
  • rash676
  • product use in unapproved indication553
  • psoriasis550
  • fatigue531
  • headache501
  • diarrhoea448
  • nausea441
  • dry skin423
  • arthralgia421
  • pain404
  • skin exfoliation399
  • erythema341

Reports by year received

View as table
YearReports
200417
200520
200658
200792
200895
2009125
2010135
2011215
2012318
2013162
2014185
2015346
2016403
2017536
2018459
2019471
2020558
2021604
2022920
20231,216
20241,152
20251,320
20261,188

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,564 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
skin exfoliationSignal3999.48.62,996
psoriasisSignal5508.47.73,580
dry skinSignal4236.35.71,890
pruritusSignal9835.14.83,276
product use in unapproved indicationSignal5534.44.11,483
erythemaSignal3413.33.0548
rashSignal6763.12.9967
arthralgiaSignal4212.01.8217
drug ineffective1,0871.61.5287
headache5011.61.5111
off label use6821.51.4137
diarrhoea4481.41.348
fatigue5311.41.251
pain4041.31.229
nausea4411.11.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.